Medigene AG Company Description

Medigene AG is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of T-cell therapies for the treatment of cancer. Medigene AG was founded in 1994 and is headquartered in Munich, Germany.

Medigene AG

Country	Germany
Founded	1994
Industry	Biotechnology
Sector	Healthcare
Employees	87
CEO	Ralph Schafer

Contact Details

Address: Lochhamer Strasse 11 Munich, 82152 Germany
Phone	49 89 2000 330
Website	medigene.com

Stock Details

Ticker Symbol	MDGEF
Exchange	OTCMKTS
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	DE000A40ESG2
SIC Code	2836

Key Executives

Name	Position
Ralph Schafer	Chief Executive Officer and Chairman of Management Board
Dr. Ernst-Ludwig Winnacker	Co-Founder and Chairman Scientific Advisory Board
Dr. Birger Kohlert	Chief Financial Officer
Pamela Keck	Vice President of Investor Relations and Corporate Communications
Dr. Kirsty Crame M.D.	Vice President and Head of Clinical Research and Development